Today, 25th of May 2016, a side event was organised by the WHO at the 69th World Health Assembly with a clear focus; Medication Safety.
“Addressing the Global Challenge of Medication Safety to Improve Patient Safety and Quality of Care”.
The side event session will review the problem of unsafe medication practices and existing challenges to medication safety; explore key strategies for the safety of medication practices, and reduction of medication errors and medication-associated harm to improve patient safety and quality of care; and introduce the next WHO Global Patient Safety Challenge on Medication Safety for high-level advocacy and call for concerted global and country actions on medication safety.
The side event is co-chaired by:
His Excellency Piotr Stachazyk, Ambassador, Permanent Representative of
Poland to the UN Office in Geneva
Sir Liam Donaldson, WHO Envoy for Patient Safety
Dr Edward Kelley, Director, Service Delivery and Safety Department, WHO
The side event is sponsored by Poland and co-sponsored by Malaysia, Oman
and Sri Lanka.
For additional information, please contact
Dr Neelam Dhingra, Coordinator, Patient Safety and Quality Improvement, WHO
We look forward to your attendance!
Shelby Kemper, PharmD, MPH
Patient Safety and Quality Improvement Unit
World Health Organization
On the 11th of April the ‘Universities Allied for Essential Medicines‘ (UAEM) organised a debate in Maastricht.
GIMS was invited as a speaker and was also possible to make the point that ‘better acces to medicines ALSO means better safety measures are necessary’.
From the PGEU website:
‘Community pharmacists have been working in the development of processes and tools to ensure Patient Safety in community pharmacies, but it is important that both community pharmacists and health policy makers realise the synergies that can arise from integrating those processes in the Patient Safety path.
Moreover, community pharmacy practice is becoming patient centred and process oriented. Dispensing the appropriate medicine and providing the relevant information and care, to the right person, at the right time is central in the community pharmacist’s daily practice. All pharmacists’ daily activities are one way or another linked to Patient Safety. That is why it is not possible to identify single initiatives towards ensuring Patient Safety in community pharmacies without contextualizing them in the community pharmacy setting, the distribution chain and the continuum of care.
However, medication safety is certainly an area where pharmacists’ expertise are of vital importance.’
On the 7th of January GIMS was happy to perform a presentation in the section ‘Work in Progress’ at the WHO Winter Meeting of the WHO Collaborating Centre for Pharmaceutical Policy and Regulation in Utrecht, The Netherlands.
Interest from the audience was generated and new contacts were made.
The Pharmaceutical Group of the European Union (PGEU), an international/European federation of the national pharmacists’ associations is completely clear in it’s mission statement;
Medication Safety is the number one topic for pharmacists.
At GIMS we clearly welcome this strategic positioning and responsibility of the pharmacists.
Positive interactions and questions followed after the GIMS presentation at the Pharmabridge session. Especially with international academics contacts can and will grow.
For the FIP congres 2016 in Buenos Aires a poster presentation is the goal.